ArticleRSC advances2026
A new dioxo-molybdenum complex derived from an amide-based imine derivative for the fluorescence recognition of Zr(iv) with phosphatase activity.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Studies on a vanadium(v) complex as highly selective fluorescence sensor for zirconium(iv) and yttrium(iii) along with catechol oxidase and phosphatase-like activities.RSC advances · 2026Article
- Dual functioning dioxo-molybdenum complex of an amide-based imine derivative: fluorescence recognition of Zr(iv) and Y(iii) with catecholase-like activity.RSC advances · 2026Article
- Exploring an azo-uracil based nickel(ii) complex for anticancer and phosphatase like activities.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An amide-imine conjugate, namely, 2,4-dihydroxy-benzoic acid-(2-hydroxy-benzylidene)-hydrazide [DBASL], was prepared from 2,4-dihydroxy benzoic acid hydrazide (DBA) and salicylaldehyde and further used for the synthesis of the corresponding Mo(vi) complex (DBASLM). The structure of DBASLM was established using different spectroscopic techniques and confirmed by single-crystal X-ray diffraction (SC-XRD) analysis. Interestingly, DBASLM selectively recognizes ZrO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.